Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 15

Gilead and PAHO Expand Access to Twice-Yearly HIV Preventi

Sep 16, 2026
Gilead Sciences has signed a new agreement with the Pan American Health Organization (PAHO) to help expand access to twice-yearly lenacapavir for HIV prevention across Latin America and…
Read More...

New Preclinical Data and Translational Advances Set to Take Center Stage at RNA-Targeted Drug…

Sep 15, 2026
The journey from RNA-targeting concept to clinical reality will be a key focus at the upcoming 9th Annual RNA-Targeted Drug Discovery & Development Summit in Boston this November.…
Read More...

Novo Nordisk Rebrands as Novo With “Lasting Health Starts Now”

Sep 15, 2026
Novo Nordisk has unveiled a major rebrand as it begins what the company describes as its next chapter, introducing the single name “Novo” and a new brand platform built around the…
Read More...

Schrödinger Launches Tectora With $55 Million Series A

Sep 14, 2026
Schrödinger has launched a new biotechnology company, Tectora, to develop potential treatments for immunology and inflammatory diseases. The company was co-founded by Schrödinger, New…
Read More...

CordenPharma Invests €80 Million in Injectable Manufacturing Expansion

Sep 14, 2026
CordenPharma is investing €80 million to expand its sterile injectable manufacturing capabilities at its Caponago site near Milan, Italy. The long-term investment program includes…
Read More...

FDA Approves Bayer’s HYRNUO for First-Line HER2-Mutated Lung Cancer

Sep 14, 2026
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Bayer’s HYRNUO (sevabertinib) as a first-line treatment for adults with locally advanced or metastatic…
Read More...

Encoded Therapeutics Raises $275 Million for Genetic Medicine Pipeline

Sep 14, 2026
Encoded Therapeutics has raised $275 million in a new financing round to advance its genetic medicine programs for severe neurological disorders, including its lead candidate ETX101 for…
Read More...

Exegenesis Bio and Modalis Advance DMD Gene Therapy Candidate

Sep 14, 2026
Exegenesis Bio and Modalis Therapeutics have entered a research collaboration and license agreement to advance MDL-201, an experimental treatment candidate for Duchenne muscular…
Read More...

FDA, Health Canada & Leading Biopharma Organizations Unite at the 2nd Model-Informed Drug…

Sep 8, 2026
Leading model-informed drug development experts to unite in Boston to explore pharmacometrics, AI, quantitative systems pharmacology, and evolving regulatory expectations The 2nd…
Read More...

Industry Leaders Convene in Boston as Registration Remains Open for the 4th TRP Supply Chain &…

Sep 8, 2026
With one week remaining until the 4th TRP Supply Chain & Manufacturing Summit, senior leaders from across the radiopharmaceutical industry are preparing to gather in Boston to…
Read More...
Previous 1 … 13 14 15 16 17 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.